Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Phibro Animal Health Corporation (PAHC) had Cost of Goods Sold of $1.01B for the most recently reported fiscal year, ending 2026-06-30.

Quarterly Annual

Figures for fiscal year ending 2026-06-30

Income Statement Financials
Revenue	$1.52B
Net Income	$99.72M
Cost of Goods Sold	$1.01B
Gross Profit	$512.51M
Operating Expenses	$1.32B
Operating Income	$194.40M
Non-Operating Income/Expense	$-57.05M
Pre-Tax Income	$137.35M
Normalized Pre-Tax Income	$137.35M
Income after Taxes	$99.72M
Income from Continuous Operations	$99.72M
Consolidated Net Income/Loss	$99.72M
Normalized Income after Taxes	$99.72M
EBIT	$194.40M
EBITDA	$248.23M
Weighted-Average Shares Outstanding (Basic)	40.55M
Weighted-Average Shares Outstanding (Diluted)	40.96M
Earnings per Share (EPS) (Basic)	$2.46
Earnings per Share (EPS) (Diluted)	$2.43
Balance Sheet Financials
Current Assets	$935.51M
Property, Plant, and Equipment	$369.17M
Long-Term Assets	$565.74M
Total Assets	$1.50B
Current Liabilities	$316.47M
Long-Term Debt	$707.77M
Long-Term Liabilities	$799.30M
Total Liabilities	$1.12B
Common Equity	$385.48M
Tangible Shareholders Equity	$295.38M
Shareholders Equity	$385.48M
Common Shares Outstanding	40.56M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$68.95M
Cash Flow from Investing Activities	$-71.45M
Cash Flow from Financial Activities	$-6.56M
Beginning Cash	$68.04M
End Cash	$61.42M
Increase/Decrease in Cash	$-6.62M
Stock-Based Compensation	$1.60M
Common Stock Dividends Paid	$-19.46M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.96
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.65
Debt to Equity Ratio	1.90
Gross Margin	33.76%
Operating Margin	12.81%
EBIT Margin	12.81%
EBITDA Margin	16.35%
Pre-Tax Profit Margin	9.05%
Profit Margin	6.57%
Free Cash Flow	$9.87M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.01
Inventory Turnover	1.88
Receiveable Turnover	6.36
Days Sales in Receivables	57.41
Return on Equity	25.87%
Return on Tangible Equity	33.76%
Return on Assets	6.64%
Return on Investments	9.12%
Book Value Per Share	$9.50
Free Cash Flow per Share	$0.24
Operating Cash Flow per Share	$1.68

Data from Zacks Investment Research, Inc.